Samuel K Reznik

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaojun Zhang, Wen Jiang, Jeremy M Richter, J Alex Bates, Samuel K Reznik, Sylwia Stachura, Richard Rampulla, Dyamanna Doddalingappa, Sankar Ulaganathan, Ji Hua, Jeffrey S Bostwick, Chi Sum, Shana Posy, Sarah Malmstrom, Joyce Dickey, David Harden, R Michael Lawrence, Victor R Guarino, William A Schumacher, Pancras Wong, Jing Yang, David A Gordon, Ruth R Wexler, E Scott Priestley
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis. Journal of medicinal chemistry (2024)
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, J Alex Bates, Samuel K Reznik, Sylwia Stachura, Richard Rampulla, Dyamanna Doddalingappa, Sankar Ulaganathan, Ji Hua, Jeffrey S Bostwick, Chi Sum, Shana Posy, Sarah Malmstrom, Joyce Dickey, David Harden, R Michael Lawrence, Victor R Guarino, William A Schumacher, Pancras Wong, Jing Yang, David A Gordon, Ruth R Wexler, E Scott Priestley
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis. Journal of medicinal chemistry 67 (5) (2024)
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, J Alex Bates, Samuel K Reznik, Sylwia Stachura, Richard Rampulla, Dyamanna Doddalingappa, Sankar Ulaganathan, Ji Hua, Jeffrey S Bostwick, Chi Sum, Shana Posy, Sarah Malmstrom, Joyce Dickey, David Harden, R Michael Lawrence, Victor R Guarino, William A Schumacher, Pancras Wong, Jing Yang, David A Gordon, Ruth R Wexler, E Scott Priestley
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis. Journal of medicinal chemistry 67 (5) (2024)
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, J Alex Bates, Samuel K Reznik, Sylwia Stachura, Richard Rampulla, Dyamanna Doddalingappa, Sankar Ulaganathan, Ji Hua, Jeffrey S Bostwick, Chi Sum, Shana Posy, Sarah Malmstrom, Joyce Dickey, David Harden, R Michael Lawrence, Victor R Guarino, William A Schumacher, Pancras Wong, Jing Yang, David A Gordon, Ruth R Wexler, Scott Priestley
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis. Journal of medicinal chemistry (2024)
Mingzong Li, Zenon Konteatis, Nelamangala Nagaraja, Yue Chen, Shubao Zhou, Guangning Ma, Stefan Gross, Katya Marjon, Marc L Hyer, Everton Mandley, Max Lein, Anil K Padyana, Lei Jin, Shuilong Tong, Rachel Peters, Joshua Murtie, Jeremy Travins, Matthew Medeiros, Peng Liu, Victoria Frank, Evan T Judd, Scott A Biller, Kevin M Marks, Zhihua Sui, Samuel K Reznik
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. Journal of medicinal chemistry 65 (6) (2022)

Samuel K Reznik.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel K Reznik